mini-kidney was grown from stem cells by scientists. Researchers have now found a way to grow aged brain cells from stem cells. And finally, Plantar Fasciitis is now being treated with stem cells.
Extensive stem cell research is being done relating to the treatment of cancer, Parkinson's disease, and multiple sclerosis. Due to all the controversy about embryonic stem cells, alternative sources are being studied, such a teeth and
umbilical cord blood.
Several companies are involved in some aspect of stem
cells and stem cell research. WallStreetNewsNetwork.com has turned up
over a dozen stem cell stocks, and over half a dozen of which are generating profits.
Pharmaceuticals (ALXN) is a Connecticut based company with a $24.6
billion market cap that is involved in the development of
biologic therapeutic products for the treatment of hematologic and
cardiovascular disorders, auto-immune diseases, and cancer. The company
licenses porcine embryonic stem cells for transgenic animals. The stock
has a price to earnings ratio of 71 and a forward PE of 37. Earnings
for the latest quarter were up 1.7%% on a 36.1% boost in
Integra Lifesciences Holdings (IART) is a New
Jersey based company that develops, manufactures, and sells medical
devices, implants, biomaterials, and instruments to the stem cell,
surgery, and soft tissue repair markets. The company recently generated a 59 cent loss per share on a 1.5% increase in sales. It has a market cap of $1.34 billion.
(CELG) is a $69.6 billion market cap company involved in the discovery
and production of therapies designed to treat cancer and
immune-inflammatory-related diseases. They have a patent on
placental stem cell recovery. The stock sports a PE ratio of 49 and a
forward PE of 23. Quarterly earnings were down 12.2%% on an 18%% revenue
For a free list of twenty stocks involved in stem cell research, along with some cord blood stocks, which you can download, sort, and update, go to WallStreetNewsNetwork.com.
Disclosure: Author did not own any of the above at the time the article was written.